Central America Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
January 14, 2015
71 Pages - SKU: BMI5441114
Countries covered: Central America

Central America Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Central America will continue to offer revenue-generating opportunities for multinationalpharmaceutical companies. An ageing population, favourable tax incentives, high per-capita medicinespending, and an improving infrastructure for medicine development and manufacturing make the regionan attractive destination for drugmakers.

Headline Expenditure Projections

Pharmaceuticals: USD3.5bn in 2013 to USD3.7bn in 2014; +4.1%. Our forecast has been revisedslightly down since Q314 due to less promising industry data.

Healthcare: USD16.0bn in 2013 to USD16.8bn in 2014; +5.1 %. Our forecast has been reviseddownwards since Q314 due to revised historical data.



More Prescription Drugs reports by Business Monitor International

Namibia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Namibia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Recent comments by the public relations officer of the Ministry of Health and Social Services,Ester Paulus, that ...
Moldova Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Moldova Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Moldovan pharmaceutical market presents limited opportunities for investors in the shortterm, but with the country opening ...
Ghana Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Ghana Pharmaceuticals and Healthcare Report Q1 2015BMI View: We anticipate that the continuing roll-out of biometric registration and expansion of thecommunity-based health planning and services ...
United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2015BMI View: The UAE will retain its position as an attractive market for innovative drugmakers due to ...
See all reports like this >>

More Central America Prescription Drugs reports

Antibiotics Market in Panama to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Panama. The study provides essential market ...
See all reports like this >>

More Central America reports

D&B Country Report: Guatemala by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
D&B Country Report: El Salvador by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Report with 3 quarterly updates  USD 1,295  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!